
On 23 May 2019, WHO received notification through the Global Polio Laboratory Network (GPLN) of the detection of circulating vaccine-derived poliovirus type 2 (cVDPV2) from an environmental sample collected on 20 April 2019 in a hospital in Northern Cameroon which borders Borno state in Nigeria and Chad.  In this region, the vaccine coverage in 2018 for inactivated poliovirus vaccine (IPV1) and oral poliovirus vaccine (OPV3) was 73% and 72% respectively. The virus was detected in an environmental sample only â€“ no associated cases of paralysis have been detected so far.